ARGEN-X Trademark

Trademark Overview

On Friday, April 3, 2009, a trademark application was filed for ARGEN-X with the United States Patent and Trademark Office. The USPTO has given the ARGEN-X trademark a serial number of 79067634. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, February 26, 2021. This trademark is owned by arGEN-X B.V.. The ARGEN-X trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Medicines, namely, antibodies for the treatment of infectious diseases and inflammation and for use in oncology [ ; medicines for the treatment of infectious diseases and inflammation and for use in oncology; medicines for autoimmune inflammatory disorders ]

Research and development in the field of biotechnology; research into new drugs and development of drugs; providing scientific and technical research services in the field of biotechnology and genetics; industrial analysis and research services in the field of biotechnology; laboratories, namely, medical laboratory services; providing information and advice in relation to the aforesaid services
argen-x

General Information

Serial Number79067634
Word MarkARGEN-X
Filing DateFriday, April 3, 2009
Status709 - CANCELLED - SECTION 71
Status DateFriday, February 26, 2021
Registration Number3793242
Registration DateTuesday, May 25, 2010
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 9, 2010

Trademark Statements

Description of MarkThe mark consists of the wording "ARGEN-X" in a stylized format.
Goods and ServicesMedicines, namely, antibodies for the treatment of infectious diseases and inflammation and for use in oncology [ ; medicines for the treatment of infectious diseases and inflammation and for use in oncology; medicines for autoimmune inflammatory disorders ]
Pseudo MarkAR GENERATION - X
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe wording "Argen-x" has no meaning in a foreign language.
Goods and ServicesResearch and development in the field of biotechnology; research into new drugs and development of drugs; providing scientific and technical research services in the field of biotechnology and genetics; industrial analysis and research services in the field of biotechnology; laboratories, namely, medical laboratory services; providing information and advice in relation to the aforesaid services

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party Nameargenx, besloten vennootschap met beperkte aansprakelijkheid
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressBE
Party Nameargenx, Societas Europaea
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressNL
Party NamearGEN-X B.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNL
Party NamearGEN-X B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNL

Trademark Events

Event DateEvent Description
Sunday, June 4, 2023NEW REPRESENTATIVE AT IB RECEIVED
Friday, January 21, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, December 23, 2021GENERIC MADRID TRANSACTION SENT TO IB
Wednesday, December 22, 2021GENERIC MADRID TRANSACTION CREATED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Thursday, June 25, 2020NEW REPRESENTATIVE AT IB RECEIVED
Saturday, May 25, 2019COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Thursday, April 18, 2019INTERNATIONAL REGISTRATION RENEWED
Thursday, October 4, 2018NEW REPRESENTATIVE AT IB RECEIVED
Thursday, May 24, 2018CHANGE OF OWNER RECEIVED FROM IB
Thursday, December 14, 2017CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, September 1, 2016CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, June 30, 2016NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Thursday, June 30, 2016REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Thursday, June 30, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, May 24, 2016TEAS SECTION 71 & 15 RECEIVED
Friday, December 4, 2015CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, July 21, 2014NEW REPRESENTATIVE AT IB RECEIVED
Friday, March 1, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, February 12, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, September 7, 2010FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, September 7, 2010FINAL DISPOSITION PROCESSED
Wednesday, August 25, 2010FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 25, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, March 9, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 9, 2010PUBLISHED FOR OPPOSITION
Friday, January 29, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 29, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 28, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 28, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 28, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 11, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 11, 2010NON-FINAL ACTION E-MAILED
Monday, January 11, 2010NON-FINAL ACTION WRITTEN
Thursday, January 7, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 7, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 6, 2010ASSIGNED TO LIE
Tuesday, January 5, 2010ASSIGNED TO EXAMINER
Tuesday, December 22, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 26, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 26, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, September 19, 2009REFUSAL PROCESSED BY IB
Wednesday, June 24, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, June 24, 2009REFUSAL PROCESSED BY MPU
Wednesday, June 24, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 23, 2009NON-FINAL ACTION WRITTEN
Tuesday, June 23, 2009ASSIGNED TO EXAMINER
Tuesday, May 19, 2009APPLICATION FILING RECEIPT MAILED
Friday, May 15, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 14, 2009SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

argen research services field medicines biotechnology drugs development providing diseases namely